Cargando…

“Cell-addictive” dual-target traceable nanodrug for Parkinson's disease treatment via flotillins pathway

α-synclein (αS) aggregation is a representative molecular feature of the pathogenesis of Parkinson's disease (PD). Epigallocatechin gallate (EGCG) can prevent αS aggregation in vitro. However, the in vivo effects of PD treatment are poor due to the obstacles of EGCG accumulation in dopaminergic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, YanHui, Chen, ZiXuan, Lu, ZhiGuo, Yang, QingHu, Liu, LinYing, Jiang, ZhaoTan, Zhang, LiQun, Zhang, Xin, Qing, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276100/ https://www.ncbi.nlm.nih.gov/pubmed/30555558 http://dx.doi.org/10.7150/thno.28295

Ejemplares similares

Research advances on flotillins
por: Zhao, Feng, et al.
Publicado: (2011)

Nanodrugs systems for therapy and diagnosis of esophageal cancer
por: Zhang, Lihan, et al.
Publicado: (2023)

The Role of Flotillins in Regulating Aβ Production, Investigated Using Flotillin 1-/-, Flotillin 2-/- Double Knockout Mice
por: Bitsikas, Vassilis, et al.
Publicado: (2014)

Preclinical Evaluation and Monitoring of the Therapeutic Response of a Dual Targeted Hyaluronic Acid Nanodrug
por: Chen, Minglong, et al.
Publicado: (2017)

Nanodrugs Detonate Lysosome Bombs
por: Xiang, Yuting, et al.
Publicado: (2022)

The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis
por: Zhang, Jin
Publicado: (2021)

Flotillin membrane domains in cancer
por: Gauthier-Rouvière, Cécile, et al.
Publicado: (2020)

Nanodrugs: pharmacokinetics and safety
por: Onoue, Satomi, et al.
Publicado: (2014)

Engineered protein nanodrug as an emerging therapeutic tool
por: Li, Yuanxin, et al.
Publicado: (2022)

Flotillin‐1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment
por: Wang, Ran, et al.
Publicado: (2023)

Dissecting the Molecular Properties of Prokaryotic Flotillins
por: Bach, Juri Niño, et al.
Publicado: (2015)

Camptothecin-based nanodrug delivery systems
por: Wen, Yan, et al.
Publicado: (2017)

Nanodrugs and Natural Pharmaceutical Products
por: Abbaspour, Mohammadreza
Publicado: (2012)

Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
por: Lin, Liteng, et al.
Publicado: (2020)

Mitochondria-Targeting Chemodynamic Therapy Nanodrugs for Cancer Treatment
por: Chen, Qiaohui, et al.
Publicado: (2022)

Traceability
por: Ashford, Paul
Publicado: (2010)

Interplay between Toxin Transport and Flotillin Localization
por: Pust, Sascha, et al.
Publicado: (2010)

Flotillins in Receptor Tyrosine Kinase Signaling and Cancer
por: Banning, Antje, et al.
Publicado: (2014)

Flotillin: A Promising Biomarker for Alzheimer’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Revolutionary Impact of Nanodrug Delivery on Neuroscience
por: Khanbabaie, Reza, et al.
Publicado: (2012)

Nanodrugs Targeting T Cells in Tumor Therapy
por: Haist, Maximilian, et al.
Publicado: (2022)

Retracted: The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis
por: Healthcare Engineering, Journal of
Publicado: (2023)

Flotillin-1 Interacts With and Sustains the Surface Levels of TRPV2 Channel
por: Hu, Juan, et al.
Publicado: (2021)

Simultaneous expression of flotillin-1, flotillin-2, stomatin and caveolin-1 in non-small cell lung cancer and soft tissue sarcomas
por: Arkhipova, Ksenia A, et al.
Publicado: (2014)

Dual-targeting inhibition of TNFR1 for alleviating rheumatoid arthritis by a novel composite nucleic acid nanodrug
por: Wang, Xiaonan, et al.
Publicado: (2023)

Research on Grain Food Blockchain Traceability Information Management Model Based on Master-Slave Multichain
por: Li, Yue, et al.
Publicado: (2022)

LEP Traceability
por: Billen, R
Publicado: (2000)

Numerical modeling of nanodrug distribution in tumors with heterogeneous vasculature
por: Chou, Cheng-Ying, et al.
Publicado: (2017)

Dynamic reorganization of flotillins in chemokine-stimulated human T-lymphocytes
por: Affentranger, Sarah, et al.
Publicado: (2011)

Flotillins Are Involved in the Polarization of Primitive and Mature Hematopoietic Cells
por: Rajendran, Lawrence, et al.
Publicado: (2009)

Genetic links between bacterial dynamin and flotillin proteins
por: Dempwolff, Felix, et al.
Publicado: (2014)

Flotillins: At the Intersection of Protein S-Palmitoylation and Lipid-Mediated Signaling
por: Kwiatkowska, Katarzyna, et al.
Publicado: (2020)

Tumor microenvironment-oriented adaptive nanodrugs based on peptide self-assembly
por: Li, Shukun, et al.
Publicado: (2020)

Dual-stimuli-responsive TiO(x)/DOX nanodrug system for lung cancer synergistic therapy
por: Dai, Zideng, et al.
Publicado: (2018)

Flotillin-2 is associated with breast cancer progression and poor survival outcomes
por: Wang, Xi, et al.
Publicado: (2013)

A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathway
por: Lu, Yu, et al.
Publicado: (2021)

Nanodrugs: optimism for emerging trend of multidrug resistance
por: Khan, Asad U
Publicado: (2012)

Critical evaluation of biodegradable polymers used in nanodrugs
por: Marin, Edgar, et al.
Publicado: (2013)

The key role of the scaffold on the efficiency of dendrimer nanodrugs
por: Caminade, Anne-Marie, et al.
Publicado: (2015)

Nanodrug Delivery Systems for the Treatment of Ovarian Cancer
por: Pantshwa, Jonathan M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_epqq4nhjs2sa743bvrueh6sqa7